ITD-1
ITD-1 is the first selective TGFβ receptor inhibitor with an IC50 of 460 nM.
Product Specifications
CAS Number
1099644-42-4
UNSPSC
12352005
Hazard Statement
H302
Target
TGF-β Receptor
Type
Reference compound
Related Pathways
TGF-beta/Smad
Applications
COVID-19-immunoregulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/ITD-1.html
Concentration
10mM
Purity
99.41
Solubility
DMSO : 28 mg/mL (ultrasonic; warming)
Smiles
O=C(C1=C(C)NC2=C(C(CC(C)(C)C2)=O)C1C3=CC=C(C4=CC=CC=C4)C=C3)OCC
Molecular Formula
C27H29NO3
Molecular Weight
415.52
Precautions
H302
References & Citations
[1]Willems E, et al. Small molecule-mediated TGF-β type II receptor degradation promotes cardiomyogenesis in embryonic stem cells. Cell Stem Cell. 2012 Aug 3;11 (2) :242-52.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740965-500 1x 500 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740633-500 1x 500 µL
Von Willebrand Factor (3E2D10), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041099-100 1x 100 µL
CD31 / PECAM-1 (C31.3 + C31.7 + C31.10), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472003-100 1x 100 µL
CD8b, Mouse (H35-17.2), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881700-100 1x 100 µL
CD44v4 (Marker of Tumor Metastasis) (CD44v4/1700R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details